Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > New Press Release - StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022
View:
Comment by LithLover on Nov 11, 2022 5:57pm
I'm curious how they ran for 4.5 months (July 1-Nov 15) and counting on 267k cash.  
Comment by Nailbiter2 on Nov 11, 2022 6:04pm
This post has been removed in accordance with Community Policy
Comment by brad129 on Nov 11, 2022 6:19pm
Cash flow positive baby, that's how come on Tripp time to show the magic.
Comment by Liked2Think on Nov 11, 2022 10:36pm
be prepared for a disappointment  it's the stage way
Comment by brad129 on Nov 11, 2022 11:22pm
Things are different now, they weren't that far from being cash positive last report. I believe they hit it now and if they did you might disappointed.
Comment by LithLover on Nov 11, 2022 11:31pm
It's been over 4 months on 90k cash and a 177k raise.  There has not been a PP. so either they have found internal financing or improved revenues.  Either us very positive.  
Comment by brad129 on Nov 11, 2022 11:41pm
That has got me waiting to see on Tuesday, aren't they early on release, hasn't it been prior to market open on the 16th a couple times?  Besides some crazy people were buying today, must have been the basementBOY is my guess.
Comment by LithLover on Nov 11, 2022 11:47pm
Financials must be filed by midnight on Monday Nov 14.  Call is pre market Tuesday.
Comment by Nailbiter2 on Nov 12, 2022 8:15am
This post has been removed in accordance with Community Policy
Comment by Nailbiter2 on Nov 11, 2022 11:40pm
This post has been removed in accordance with Community Policy
StageZero Life Sciences Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities